Report on the Sixth Conference on Retroviruses and Opportunistic Infections.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The Sixth Conference on Retroviruses and Opportunistic Infections has provided HIV research with exciting advances in understanding the mechanisms of HIV disease and treatment. However, few answers were found to important clinical questions, such as when to begin antiretroviral therapy. The most important presentations are summarized and grouped by major issues. Advances in combination therapy were discussed, including new information on the effectiveness of PI-sparing antiretroviral combinations and the promising results seen with ABT-378, a "second generation" PI. Research was also presented on the decline of opportunistic infections since the advent of HAART, the increased focus on metabolic consequences, and the importance of adherence. Further study is required to find solutions for patients failing HAART and to make treatment available to those who need it.

Original languageEnglish (US)
JournalAIDS clinical care
Volume11
Issue number4
StatePublished - 1999
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
HIV
Lopinavir
Opportunistic Infections
Therapeutics
Research

Cite this

Report on the Sixth Conference on Retroviruses and Opportunistic Infections. / Soloway, Bruce H.

In: AIDS clinical care, Vol. 11, No. 4, 1999.

Research output: Contribution to journalArticle

@article{d6f5f1d94aa94146b8f9c8242c594b0c,
title = "Report on the Sixth Conference on Retroviruses and Opportunistic Infections.",
abstract = "The Sixth Conference on Retroviruses and Opportunistic Infections has provided HIV research with exciting advances in understanding the mechanisms of HIV disease and treatment. However, few answers were found to important clinical questions, such as when to begin antiretroviral therapy. The most important presentations are summarized and grouped by major issues. Advances in combination therapy were discussed, including new information on the effectiveness of PI-sparing antiretroviral combinations and the promising results seen with ABT-378, a {"}second generation{"} PI. Research was also presented on the decline of opportunistic infections since the advent of HAART, the increased focus on metabolic consequences, and the importance of adherence. Further study is required to find solutions for patients failing HAART and to make treatment available to those who need it.",
author = "Soloway, {Bruce H.}",
year = "1999",
language = "English (US)",
volume = "11",
journal = "AIDS clinical care",
issn = "1043-1543",
publisher = "Massachussetts Medical Society",
number = "4",

}

TY - JOUR

T1 - Report on the Sixth Conference on Retroviruses and Opportunistic Infections.

AU - Soloway, Bruce H.

PY - 1999

Y1 - 1999

N2 - The Sixth Conference on Retroviruses and Opportunistic Infections has provided HIV research with exciting advances in understanding the mechanisms of HIV disease and treatment. However, few answers were found to important clinical questions, such as when to begin antiretroviral therapy. The most important presentations are summarized and grouped by major issues. Advances in combination therapy were discussed, including new information on the effectiveness of PI-sparing antiretroviral combinations and the promising results seen with ABT-378, a "second generation" PI. Research was also presented on the decline of opportunistic infections since the advent of HAART, the increased focus on metabolic consequences, and the importance of adherence. Further study is required to find solutions for patients failing HAART and to make treatment available to those who need it.

AB - The Sixth Conference on Retroviruses and Opportunistic Infections has provided HIV research with exciting advances in understanding the mechanisms of HIV disease and treatment. However, few answers were found to important clinical questions, such as when to begin antiretroviral therapy. The most important presentations are summarized and grouped by major issues. Advances in combination therapy were discussed, including new information on the effectiveness of PI-sparing antiretroviral combinations and the promising results seen with ABT-378, a "second generation" PI. Research was also presented on the decline of opportunistic infections since the advent of HAART, the increased focus on metabolic consequences, and the importance of adherence. Further study is required to find solutions for patients failing HAART and to make treatment available to those who need it.

UR - http://www.scopus.com/inward/record.url?scp=0033107841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033107841&partnerID=8YFLogxK

M3 - Article

C2 - 2000141872

AN - SCOPUS:0033107841

VL - 11

JO - AIDS clinical care

JF - AIDS clinical care

SN - 1043-1543

IS - 4

ER -